But, finasteride 5 mg/day showed moderate to significant improvement and was found to be safe for the treatment of female AGA in postmenopausal women in the absence of hyper-androgenism.

The FDA also warned that the spray could pose a risk to others, especially women. Finasteride can cause birth defects in male ...

I realized while reading your recent column that I have the sexual side effects the letter-writer described. I had been unable to obtain a satisfactory erection even when taking 150 mg of sildenafil, ...

There is no FDA-approved topical formulation of finasteride, and compounded topical finasteride products do not have ...

All participants received 5 mg/day finasteride and were randomly assigned to receive either counseling on the potential sexual adverse effects of the drug or no such counseling. Using patients ...

FDA warning on topical finasteride: The FDA issued a warning about the topical form of finasteride (generic Propecia), often ...

Lancet Oncol 8: 21–25 Finasteride, a type 2 5α-reductase inhibitor, is used to treat benign prostatic hyperplasia (BPH) at 5 mg daily, and male-pattern alopecia at 1 mg daily. The 5 mg regimen ...

Patients received ER alfuzosin 5 mg twice daily, finasteride 5 mg daily, or both drugs for six months. Alfuzosin alone and alfuzosin-finasteride combination therapy significantly improved symptoms ...